These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37262315)

  • 1. Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways.
    Mahmoud Refaie MM; Ahmed Rifaai R; Bayoumi AMA; Shehata S
    J Pharm Pharmacol; 2023 Sep; 75(9):1237-1248. PubMed ID: 37262315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacubitril/valsartan alleviates sepsis-induced myocardial injury in rats via dual angiotensin receptor-neprilysin inhibition and modulation of inflammasome/caspase 1/IL1β pathway.
    Refaie MMM; El-Hussieny M; Bayoumi AMA; Abdelraheem WM; Abdel-Hakeem EA; Shehata S
    Eur J Pharmacol; 2024 Sep; 979():176834. PubMed ID: 39038638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hypoxia inducible factor/vascular endothelial growth factor/endothelial nitric oxide synthase signaling pathway in mediating the cardioprotective effect of dapagliflozin in cyclophosphamide-induced cardiotoxicity.
    Mahmoud Refaie MM; Bayoumi AM; Mokhemer SA; Shehata S; Abd El-Hameed NM
    Hum Exp Toxicol; 2023; 42():9603271231193392. PubMed ID: 37526264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway.
    Refaie MMM; Amin EF; Hassan MN; Rifaai RA; Bayoumi AMA; Kamel MY
    J Pharm Pharmacol; 2024 Jul; 76(7):788-797. PubMed ID: 38538077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway.
    Dindaş F; Güngör H; Ekici M; Akokay P; Erhan F; Doğduş M; Yılmaz MB
    Anatol J Cardiol; 2021 Nov; 25(11):821-828. PubMed ID: 34734816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin cardioprotection in cyclophosphamide-induced toxicity via the modulation of inflammasome/caspase1/interleukin1β pathway.
    Refaie MM; El-Hussieny M; Bayoumi AM; Shehata S; Welson NN; Abdelzaher WY
    Hum Exp Toxicol; 2022; 41():9603271221111440. PubMed ID: 35762198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effects of bosentan in 5-fluorouracil-induced cardiotoxicity.
    Refaie MMM; Abdel-Gaber SA; Rahman SAAE; Hafez SMNA; Khalaf HM
    Toxicology; 2022 Jan; 465():153042. PubMed ID: 34800596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ATP-Sensitive Potassium Channel (K
    Refaie MMM; Shehata S; El-Hussieny M; Abdelraheem WM; Bayoumi AMA
    Cardiovasc Toxicol; 2020 Feb; 20(1):71-81. PubMed ID: 31230218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and appraisal of self-assembled valsartan-loaded amalgamated Pluronic F127/Tween 80 polymeric micelles: Boosted cardioprotection
    Aboud HM; Mahmoud MO; Abdeltawab Mohammed M; Shafiq Awad M; Sabry D
    J Drug Target; 2020 Mar; 28(3):282-299. PubMed ID: 31353972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of empagliflozin cardioprotection in 5-fluorouracil (5-FU)-induced cardiotoxicity via modulation of SGLT2 and TNFα/TLR/NF-κB signaling pathway in rats.
    Refaie MMM; Shehata S; El-Hussieny M; Fawzy MA; Ahmed NZM; Marey H; Hishmat AM; Alkully T; Rahman ESMAE
    Toxicol Res; 2024 Jan; 40(1):139-151. PubMed ID: 38223670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.
    Refaie MMM; Rifaai RA; Fawzy MA; Shehata S
    Cardiovasc Toxicol; 2022 Nov; 22(10-11):916-928. PubMed ID: 36242756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effect of hemin in isoprenaline-induced myocardial infarction: role of ATP-sensitive potassium channel and endothelial nitric oxide synthase.
    Refaie MMM; Rifaai RA; Bayoumi AMA; Shehata S
    Fundam Clin Pharmacol; 2020 Jun; 34(3):302-312. PubMed ID: 31854010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of valsartan against doxorubicin-induced cardiotoxicity: Histopathology and metabolomics in vivo study.
    Alhazzani K; Alotaibi MR; Alotaibi FN; Aljerian K; As Sobeai HM; Alhoshani AR; Alanazi AZ; Alanazi WA; Alswayyed M
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22842. PubMed ID: 34273911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells.
    Bayraktutan U
    J Hypertens; 2003 Nov; 21(11):2093-101. PubMed ID: 14597853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity.
    Boutagy NE; Feher A; Pfau D; Liu Z; Guerrera NM; Freeburg LA; Womack SJ; Hoenes AC; Zeiss C; Young LH; Spinale FG; Sinusas AJ
    JACC CardioOncol; 2020 Dec; 2(5):774-787. PubMed ID: 33437965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats.
    Imran M; Hassan MQ; Akhtar MS; Rahman O; Akhtar M; Najmi AK
    Clin Exp Hypertens; 2019; 41(1):62-69. PubMed ID: 29595329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacubitril/valsartan reduces endoplasmic reticulum stress in a rat model of doxorubicin-induced cardiotoxicity.
    Kim BS; Park IH; Lee AH; Kim HJ; Lim YH; Shin JH
    Arch Toxicol; 2022 Apr; 96(4):1065-1074. PubMed ID: 35152301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in
    Myakala K; Jones BA; Wang XX; Levi M
    Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1133-F1151. PubMed ID: 33870733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sacubitril/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect.
    Tashiro K; Kuwano T; Ideishi A; Morita H; Idemoto Y; Goto M; Suematsu Y; Miura SI
    Cardiol Res; 2020 Dec; 11(6):376-385. PubMed ID: 33224383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of Nrf2/HO-1/cytoglobin and Ang-II/NF-κB signals in the cardioprotective mechanism of lansoprazole against cisplatin-induced heart injury.
    Hassanein EHM; Ali FEM; Mohammedsaleh ZM; Atwa AM; Elfiky M
    Toxicol Mech Methods; 2023 May; 33(4):316-326. PubMed ID: 36258671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.